Negotiating IP Rights in Industry Sponsored Research Agreements
Structuring Ownership, Licensing, Assignment, Confidentiality, Publication and Use Provisions
Recording of a 90-minute CLE webinar with Q&A
This CLE webinar will guide counsel on negotiating and structuring industry sponsored research agreements (SRAs) to allocate IP ownership. The panel will outline challenges of SRAs with nonprofit organizations and discuss key provisions of the SRA to protect IP rights and avoid unintended consequences.
- Key provisions
- Ownership of IP
- Rights to future IP
The panel will review these and other principal issues:
- What are the primary considerations for counsel when negotiating the SRA?
- What are best practices for addressing IP ownership and rights in an SRA?
- What challenges do multiple licenses create and how can counsel overcome those challenges?
Jeremy A. Cubert
Potomac Law Group
With over 22 years of experience in patent law with an emphasis in life sciences, Mr. Cubert assists companies in all... | Read More
With over 22 years of experience in patent law with an emphasis in life sciences, Mr. Cubert assists companies in all aspects of obtaining and managing their IP portfolios. He has extensive experience in patent prosecution, due diligence and analysis of IP portfolios and counsels clients regarding the acquisition and licensing of IP assets. Mr. Cubert regularly works directly with scientists and professionals at academic institutions, biotechnology companies, and Fortune 500 companies to develop IP development and management plans. Mr. Cubert has been an adjunct professor at the American University Washington College of Law where he taught a course entitled “Intellectual Property Law and Healthcare” and has authored many articles in the area of IP law.Close
Jeffrey D. Morton, Ph.D.
Snell & Wilmer
Mr. Morton routinely represents both start-up and large enterprises for their intellectual property, technology and... | Read More
Mr. Morton routinely represents both start-up and large enterprises for their intellectual property, technology and commercial law needs. His practice focuses on all aspects of IP and technology law, with particular experience in the life sciences industry. Mr. Morton has significant patent prosecution experience in a wide range of technologies including immunotherapeutics for treating diabetes, HIV and cancer, DNA sequencing methods and related devices, and agricultural products such as transgenic seeds. His experience covers a wide range of industries, and includes preparing and negotiating patent license agreements and sponsored research agreements, and advising on IP issues in asset sale and merger transactions.Close